Anesthesia Dolorosa

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 255 Experts worldwide ranked by ideXlab platform

J R Schvarcz - One of the best experts on this subject based on the ideXlab platform.

  • stereotactic trigeminal nucleotomy for dysesthetic facial pain
    Stereotactic and Functional Neurosurgery, 1997
    Co-Authors: J R Schvarcz
    Abstract:

    Trigeminal nucleotomy is a relatively simple, straightforward stereotactic procedure, acting at the deafferentation site, i.e., at the nucleus caudalis. Patients were operated on in a seated position, by a posterior suboccipital approach. Out of a series of 196 patients, 143 underwent trigeminal nucleotomy for deafferentation. Clinical diagnoses were 52 cases of postherpetic pain dysesthesia, 35 of Anesthesia Dolorosa, 46 of dysesthetic state with superimposed tic-like sequelae of trigeminal surgery performed elsewhere and 9 of posttraumatic neuropathy. Abolition of allo-dynia or marked reduction in, or disappearance of deep background pain was achieved in 72.0% of the cases overall. Results are analyzed for each clinical category. There were no side effects of any kind. Follow-up ranged from 4 to 17 years. This seems to be the procedure of choice for deafferentation facial pain.

Sergio Canavero - One of the best experts on this subject based on the ideXlab platform.

  • how frequent is Anesthesia Dolorosa following spinal posterior rhizotomy a retrospective analysis of fifteen patients
    Pain, 1993
    Co-Authors: C A Pagni, Michele Maria Rosario Lanotte, Sergio Canavero
    Abstract:

    Abstract Anesthesia Dolorosa has been considered an unfrequent complication of spinal posterior rhizotomy. We reviewed the data of all patients who underwent rhizotomy between 1962 and 1972 (15 cases). Thirteen were affected by cancer and 2 by non-neoplastic conditions. Eight developed a typical deafferentation pain (i.e., Anesthesia Dolorosa) (53%) while 3 who were found to have a brain (frontal 2; parietal 1) metastasis did not. Anesthesia Dolorosa developed 1.5–8 months after rhizotomy. We conclude that Anesthesia Dolorosa following rhizotomy is more frequent than usually stated and that rhizotomy should be restricted to patients with a less than 3-month life expectancy.

  • The role of cortex in central pain syndromes: preliminary results of a long-term technetium-99 hexamethylpropyleneamineoxime single photon emission computed tomography study.
    Neurosurgery, 1993
    Co-Authors: Sergio Canavero, Carlo Alberto Pagni, Giancarlo Castellano, Vincenzo Bonicalzi, Marilena Bellò, Sergio Duca, Valerio Podio
    Abstract:

    : The role of the somatosensory cortex in central pain syndromes is widely questioned. Two recent position emission tomography studies detected a strong activation of the parietal and cingular cortices after brief nociceptive stimuli. On the other hand, a recent single photon emission computed tomography study found no cortical activation in five patients affected by central poststroke pain and algodystrophia. In this study, we present the single photon emission computed tomography findings in five patients suffering from central pain syndromes. Two of these, one with facial postrhizotomy Anesthesia Dolorosa and the other with central poststroke pain, showed a decrease of blood flow in the parietal lobe, further decreasing after stimulation by nonpainful maneuvers. Our results suggest that somatosensory cortical areas might be involved in the generation of anomalous pain states in some cases of central pain syndromes.

Amr O Elnaggar - One of the best experts on this subject based on the ideXlab platform.

  • nucleus caudalis dorsal root entry zone lesioning for the treatment of Anesthesia Dolorosa
    Journal of Neurosurgery, 2013
    Co-Authors: Stephen Sandwell, Amr O Elnaggar
    Abstract:

    Deafferentation facial pain (Anesthesia Dolorosa) can occur after injury of the first-order trigeminal nerve. It is often debilitating and difficult to treat. The authors report the treatment of Anesthesia Dolorosa in a 69-year-old man with a 7-year history of pain. The pain occurred after an open resection of a right trigeminal neuroma. After treatment with medications failed, the patient was treated with nucleus caudalis (dorsal root entry zone) lesioning. His facial pain was immediately and completely eliminated. The authors describe the technique of this central neuroablative procedure, and they review the available literature regarding this procedure as well as the current evidence base for neuromodulatory surgeries. After the 1-year follow-up, the authors conclude that the patient attained lasting relief.

Wook Park - One of the best experts on this subject based on the ideXlab platform.

  • Anesthesia Dolorosa following retrogasserian glycerol injection for trigeminal neuralgia
    The Korean Journal of Pain, 1995
    Co-Authors: Jongsoo Yoon, Wook Park
    Abstract:

    Percutaneous retrogasserian gangliolysis is suitable for treatment of trigeminal neuralgia because it is simple and effective. Further, it can avoid severe complications such as Anesthesia Dolorosa or dysesthesia that may develop after surgical procedure. However we have experienced an Anesthesia Dolorosa(pain in an area or region that is anesthetic) after percutaneous retrogasserian glycerol injection. This deafferentation pain is characterized by scratching, burning or itching sensation; and has shown to be of higher incidence in older and inemotionally unstable patients. Anesthesia Dolorosa is relatively rare but difficult to treat. Consideration should be made for the complication which may develop during the procedure.

  • Percutaneous Retrogasserian Glycerol Rhizolysis in the Management of Trigeminal Neuralgia
    The Korean Journal of Pain, 1991
    Co-Authors: Wook Park
    Abstract:

    【Percutaneous retrogasserian glycerol rhizolysis(PRGR) was performed in 43 patients, a total of 65 times, for the management of typical trigeminal neuralgia from 1987 to 1991. The age of patients was distributed between 19 and 87 years. According to sex 17 were male and 26 were female. Pure glycerol of 0.3-0.8 ml was injected into the Meckel's cave on the affected site. In 31 PRGR(Group I) that had cisternography to titrate the dose of glycerol, when treated, 26 G of these PRGR patients(83.9%) had relief of pain. There were recurrence of pain in 7PRGR (22.6%) and the average interval from the PRGR to recurrence of pain in 7 PRGR(22.6%) and the average interval from the PRGR to recurrence of pain was 16.9 months. In 34 PRGR(Group II) of which bupivacaine was injected to titrate the dose of glycerol, 29 PRGR(85.3%) had relief of pain 80 howing treatment. There were recurrence of pain in 8 PRGR(23.5%) and the average interval from the PRGR to the recurrence of pain was 14.3 months. Finally of all procedures done(65 PRGR), 55 PRGR(84.6%) had relief of pain. There were recurrence of pain in 15 PRGR(23.1%) and the average interval from the PRGR to recurrence of pain was 15.5 months. There was no significant difference between the two groups in the rate of pain relief. There were conjunctival irritation(3 cases), headache(2), vomiting(3), hematoma(2), and herpes simplex(3) as transient complications after PRGR. Corneal ulceration and Anesthesia Dolorosa did not develop in any cases.】

C A Pagni - One of the best experts on this subject based on the ideXlab platform.